Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IN › ANDERSON › COMMUNITY HOSPITAL OF ANDERSON & MADISON COUNTY, INC

COMMUNITY HOSPITAL OF ANDERSON & MADISON COUNTY, INC

NPI: 1972500452 · ANDERSON, IN 46011 · General Acute Care Hospital · NPI assigned 06/30/2005

$32.30M
Total Medicaid Paid
679,692
Total Claims
546,343
Beneficiaries
179
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMILLARD, HOLLY (FINANCE)
NPI Enumeration Date06/30/2005

Related Entities

Other providers sharing the same authorized official: MILLARD, HOLLY

ProviderCityStateTotal Paid
COMMUNITY HEALTH NETWORK, INC INDIANAPOLIS IN $161.73M
COMMUNITY HEALTH NETWORK, INC INDIANAPOLIS IN $32.97M
COMMUNITY HOSPITAL SOUTH, INC. INDIANAPOLIS IN $27.35M
FAIRBANKS HOSPITAL, INC. INDIANAPOLIS IN $18.54M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 81,026 $1.43M
2019 68,978 $2.66M
2020 55,501 $2.40M
2021 101,042 $5.25M
2022 147,174 $7.37M
2023 127,515 $7.56M
2024 98,456 $5.63M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 46,194 40,474 $7.02M
99284 Emergency department visit for the evaluation and management, high severity 45,212 37,953 $6.76M
71045 Radiologic examination, chest; single view 16,334 13,580 $2.20M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 15,966 13,253 $1.80M
74177 Computed tomography, abdomen and pelvis; with contrast material 4,585 3,745 $1.59M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 25,494 20,624 $1.51M
88305 Level IV - Surgical pathology, gross and microscopic examination 5,972 5,061 $1.33M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,728 6,203 $931K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 7,712 5,214 $877K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2,084 895 $857K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 18,561 15,255 $775K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,303 1,723 $638K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 8,871 7,531 $565K
71046 Radiologic examination, chest; 2 views 7,168 6,154 $539K
96361 Intravenous infusion, hydration; each additional hour 11,301 9,141 $495K
70450 Computed tomography, head or brain; without contrast material 4,592 3,613 $453K
80050 General health panel 1,962 1,851 $371K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 73,115 57,414 $281K
96375 Therapeutic injection; each additional sequential IV push 12,292 9,302 $259K
87428 8,561 7,534 $228K
36415 Collection of venous blood by venipuncture 98,765 77,635 $194K
80048 Basic metabolic panel (calcium, ionized) 46,496 37,369 $192K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,689 1,568 $172K
77067 Screening mammography, bilateral, including computer-aided detection 742 719 $163K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 652 459 $162K
94761 5,079 4,211 $144K
80053 Comprehensive metabolic panel 27,432 20,514 $137K
84484 20,527 12,864 $125K
74176 Computed tomography, abdomen and pelvis; without contrast material 406 292 $73K
80061 Lipid panel 9,737 8,507 $72K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,165 979 $68K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,681 1,576 $60K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,492 1,234 $60K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,564 2,243 $59K
77336 460 153 $55K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 65 51 $54K
81025 9,444 8,105 $52K
80076 9,275 7,632 $44K
77063 Screening digital breast tomosynthesis, bilateral 742 719 $44K
84443 Thyroid stimulating hormone (TSH) 4,961 4,242 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,501 2,176 $37K
83690 11,539 9,457 $37K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 469 401 $34K
81001 20,017 16,792 $34K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 23 14 $28K
87807 2,862 2,651 $27K
71260 Computed tomography, thorax, diagnostic; with contrast material 123 106 $26K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 794 754 $25K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 793 753 $25K
86481 399 386 $25K
82607 2,440 2,188 $24K
86703 1,998 1,837 $23K
87086 Culture, bacterial; quantitative colony count, urine 4,442 3,657 $22K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,092 913 $21K
95819 41 38 $20K
64615 110 87 $20K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 937 868 $20K
86803 1,558 1,446 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 501 418 $19K
87653 751 660 $19K
86480 324 311 $18K
97161 197 160 $18K
83036 Hemoglobin; glycosylated (A1C) 3,074 2,723 $17K
86708 1,453 1,385 $17K
59025 Fetal non-stress test 189 126 $17K
93017 145 116 $17K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 65 51 $16K
86706 1,504 1,436 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 855 694 $15K
80074 240 235 $11K
83735 2,332 1,826 $9K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 74 63 $9K
81003 7,322 6,082 $9K
83880 515 394 $8K
77334 53 24 $8K
86592 2,135 1,997 $8K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 331 269 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 180 144 $7K
86140 2,682 2,330 $7K
95886 14 14 $7K
76705 Ultrasound, abdominal, real time with image documentation; limited 59 56 $6K
71275 Computed tomographic angiography, chest, with contrast material 12 12 $6K
72125 Computed tomography, cervical spine; without contrast material 29 24 $6K
82977 741 704 $5K
82746 662 562 $5K
82728 684 585 $5K
84439 1,006 782 $5K
87522 Neg quan hep c or qual rna 106 99 $4K
86235 117 52 $4K
83550 778 672 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 408 347 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 79 72 $4K
85652 2,562 2,218 $4K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 102 85 $3K
83540 777 671 $3K
86200 414 332 $3K
77300 16 12 $3K
87340 354 324 $2K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 35 25 $2K
72202 44 43 $2K
86787 291 257 $2K
86705 199 184 $2K
86038 330 253 $2K
72100 65 52 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 25 24 $2K
36416 418 302 $2K
87631 34 31 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 88 25 $2K
87536 29 26 $2K
87081 386 343 $2K
85379 253 225 $2K
84550 730 625 $1K
80055 59 45 $1K
82570 460 404 $1K
85027 271 250 $1K
94060 19 12 $1K
82043 379 340 $1K
74018 30 26 $1K
84460 401 340 $1K
82550 764 418 $1K
86762 112 103 $1K
82955 169 130 $857.98
84702 59 39 $755.73
86431 251 181 $685.58
86850 173 160 $584.11
94726 67 48 $545.54
73130 17 13 $530.72
82553 534 217 $501.38
86160 46 37 $489.19
84146 26 25 $479.53
80069 92 81 $465.25
82950 123 113 $413.91
80305 55 52 $399.18
83605 64 44 $298.95
96376 105 79 $295.62
86361 16 14 $252.76
82962 185 102 $240.84
86900 111 103 $218.30
86901 111 103 $195.23
87905 50 48 $194.78
86225 33 25 $186.86
J1790 Injection, droperidol, up to 5 mg 170 143 $186.40
85610 128 76 $185.46
87040 24 13 $160.16
83516 34 25 $156.81
87077 30 24 $129.28
86709 14 13 $123.86
J2795 Injection, ropivacaine hydrochloride, 1 mg 837 573 $121.41
87808 12 12 $120.48
84156 48 40 $108.50
85007 28 26 $79.69
82947 18 14 $78.83
83020 16 12 $77.53
84100 30 24 $76.26
82610 14 14 $75.75
81015 35 33 $45.55
87210 26 24 $33.84
82248 17 13 $29.22
J2270 Injection, morphine sulfate, up to 10 mg 1,260 749 $21.17
J0585 Injection, onabotulinumtoxina, 1 unit 144 91 $18.30
85014 14 12 $13.42
85018 14 12 $13.42
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,993 3,008 $12.05
J1885 Injection, ketorolac tromethamine, per 15 mg 1,442 1,240 $8.36
84450 12 12 $6.98
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 1,423 1,153 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 120 100 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 18 14 $0.00
99080 54 19 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 13 12 $0.00
94729 47 36 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 1,112 640 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 366 252 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 65 51 $0.00
J2704 Injection, propofol, 10 mg 515 412 $0.00
88304 37 25 $0.00
J0690 Injection, cefazolin sodium, 500 mg 391 190 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 87 73 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 14 13 $0.00